Injectable treatment with cabotegravir and rilpivirine proved just as effective in maintaining viral suppression as standard oral antiretroviral treatment in a large trial in Africa, despite less intensive viral load monitoring than previous studies,

https://www.aidsmap.com/news/mar-2024/injectable-treatment-just-effective-standard-hiv-combination-africa: Injectable treatment just as effective as standard HIV combination in Africa